Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experience.

Erdheim–Chester disease giant cell tumor of tendon sheath histiocytes immunoglobulin G4-related disease osteopoikilosis

Journal

The oncologist
ISSN: 1549-490X
Titre abrégé: Oncologist
Pays: England
ID NLM: 9607837

Informations de publication

Date de publication:
04 03 2022
Historique:
received: 27 07 2021
accepted: 29 09 2021
entrez: 31 5 2022
pubmed: 1 6 2022
medline: 3 6 2022
Statut: ppublish

Résumé

Histiocytic disorders pose significant diagnostic and management challenges for the clinicians due to diverse clinical manifestations and often non-specific histopathologic findings. Herein, we report the tumor board experience from the first-of-its-kind Histiocytosis Working Group (HWG). The HWG was established in June 2017 and consists of experts from 10 subspecialties that discuss cases in a multidisciplinary format. We present the outcome of tumor board case discussions during the first 2 years since its inception (June 2017-June 2019). Forty cases with a suspected histiocytic disorder were reviewed at HWG during this time period. Average number of subspecialties involved in HWG case discussion was 5 (range, 2-9). Histiocytosis Working Group tumor board recommendations led to significant changes in the care of 24 (60%) patients. These included change in diagnosis (n = 11, 27%) and change in treatment (n = 13, 33%). Our report highlights the feasibility of a multidisciplinary tumor board and its impact on outcomes of patients with histiocytic disorders.

Identifiants

pubmed: 35641201
pii: 6518010
doi: 10.1093/oncolo/oyab031
pmc: PMC8895750
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

144-148

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press.

Références

Clin Case Rep. 2018 Jun 22;6(8):1637-1638
pubmed: 30147924
Cancer Discov. 2016 Feb;6(2):154-65
pubmed: 26566875
Br J Haematol. 2018 Aug;182(4):579-581
pubmed: 28653448
Radiographics. 2011 Nov-Dec;31(7):1865-82
pubmed: 22084176
Blood. 2016 Jun 2;127(22):2672-81
pubmed: 26966089
Leuk Lymphoma. 2017 Jan;58(1):251-252
pubmed: 27282880
Mayo Clin Proc. 2019 Oct;94(10):2054-2071
pubmed: 31472931
JCO Oncol Pract. 2021 Jan;17(1):30
pubmed: 32840423
JAMA Oncol. 2017 Sep 01;3(9):1253-1256
pubmed: 28253394
Blood. 2020 May 28;135(22):1929-1945
pubmed: 32187362

Auteurs

Gaurav Goyal (G)

Division of Hematology-Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
Division of Hematology, Mayo Clinic, Rochester, MN, USA.

Jason R Young (JR)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Jithma P Abeykoon (JP)

Division of Hematology, Mayo Clinic, Rochester, MN, USA.

Mithun V Shah (MV)

Division of Hematology, Mayo Clinic, Rochester, MN, USA.

N Nora Bennani (NN)

Division of Hematology, Mayo Clinic, Rochester, MN, USA.

Julio C Sartori-Valinotti (JC)

Department of Dermatology, Mayo Clinic, Rochester, MN, USA.

Robert Vassallo (R)

Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.

Jay H Ryu (JH)

Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.

W Oliver Tobin (WO)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Matthew J Koster (MJ)

Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.

Caroline J Davidge-Pitts (CJ)

Division of Endocrinology, Diabetes, and Nutrition, Mayo Clinic, Rochester, MN, USA.

Aishwarya Ravindran (A)

Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Karen L Rech (KL)

Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Ronald S Go (RS)

Division of Hematology, Mayo Clinic, Rochester, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH